Author: oncologs.com

“[…] as far as we know, we are the first to provide evidence of [stem cell depletion in aging] in a pan-tissue manner.” Credit: 2024 Santos et al. “[…] as far as we know, we are the first to provide evidence of [stem cell depletion

New research from the University of Pittsburgh explains why metastatic uveal melanoma is resistant to conventional immunotherapies and how adoptive therapy, which involves growing a patient’s T cells outside the body before reinfusing them, can successfully treat this rare and aggressive cancer. Credit: UPMC New

Osaka, Japan – Antisense oligonucleotides (ASOs) are next-generation drugs that can treat disease by blocking the transfer of harmful messages from our genes. In people with cancer, ASOs have the potential to block messages that encourage the growth and spread of the tumor. However, ASOs

**Embargo: 23.30 [UK time] / 19.30 [ET], Monday 15 April 2024**  Credit: The Lancet **Embargo: 23.30 [UK time] / 19.30 [ET], Monday 15 April 2024**  Peer-reviewed/Literature review, Survey, and Opinion/People Embargoed access to the papers and contact details for authors and patient advocates are available

Drug-loaded 3D printed films could change cancer treatments forever as world first research from the University of South Australia shows that new films not only kill more than 80% of liver cancer cells but could also significantly reduce recurrence rates while minimising systematic toxicities of

MIAMI, FLORIDA (April 12, 2024) – An advisory committee at the U.S. Food and Drug Administration voted 12-0 today in favor of a major shift in how the agency evaluates new treatments for multiple myeloma. The FDA often adopts the recommendations of its expert committees,

Neli Ulrich, PhD, MS, chief scientific officer and executive director of the Comprehensive Cancer Center atHuntsman Cancer Institute at the University of Utah (the U) and professor of Population Health Sciences at the U, has been awarded the 2024 Governor’s Medal for Science and Technology.  Credit: Huntsman Cancer Institute

PLYMOUTH MEETING, PA [April 15, 2024] — The National Comprehensive Cancer Network® (NCCN®) and the NCCN Foundation® today announced five winners for the 2024 NCCN Foundation Young Investigator Awards (YIA). These annual awards honor some of the most promising new oncology researchers from across NCCN’s

A new study conducted by researchers at Tampere University and Tampere University Hospital revealed how aberrant epigenetic regulation contributes to the development of atypical teratoid/rhabdoid (AT/RT) tumours, which are aggressive brain tumours that mainly affect young children. There is an urgent need for more research

New research from the University of Oklahoma reveals a previously unknown chain of events sparking the development of cancer cachexia, a debilitating muscle-wasting condition that almost always occurs in people diagnosed with pancreatic cancer. Credit: University of Oklahoma New research from the University of Oklahoma